Dr. Renuka V. Iyer
Claim this profileRoswell Park Cancer Institute
Studies Skin Cancer
Studies Cancer
15 reported clinical trials
30 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
GPC3 positive
2Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Renuka V. Iyer is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting1 award Phase 23 criteria
Iadademstat + Paclitaxel
for Lung Cancer
This is a non-randomized single-arm, two cohorts, phase II study of iadademstat in combination with weekly paclitaxel in patients with relapse/refractory SCLC or extrapulmonary G3 Neuroendocrine Carcinomas. A total of 42 patients with SCLC (21 patients) and G3 NEC (21 patients) will be enrolled (including those enrolled in the safety lead-in portion).
Recruiting2 awards Phase 214 criteria
More about Renuka V. Iyer
Clinical Trial Related4 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Renuka V. Iyer has experience with
- Atezolizumab
- Cabozantinib
- Cisplatin
- SVN53-67/M57-KLH Peptide Vaccine
- SurVaxM
- Temozolomide
Breakdown of trials Renuka V. Iyer has run
Skin Cancer
Cancer
Neuroendocrine Tumors
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Renuka V. Iyer specialize in?
Renuka V. Iyer focuses on Skin Cancer and Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Renuka V. Iyer currently recruiting for clinical trials?
Yes, Renuka V. Iyer is currently recruiting for 6 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Renuka V. Iyer has studied deeply?
Yes, Renuka V. Iyer has studied treatments such as Atezolizumab, Cabozantinib, Cisplatin.
What is the best way to schedule an appointment with Renuka V. Iyer?
Apply for one of the trials that Renuka V. Iyer is conducting.
What is the office address of Renuka V. Iyer?
The office of Renuka V. Iyer is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.